Pomalidomide is active in the treatment of anemia associated with myelofibrosis

Ayalew Tefferi*, Srdan Verstovsek, Giovanni Barosi, Francesco Passamonti, Gail J. Roboz, Heinz Gisslinger, Ronald L. Paquette, Francisco Cervantes, Candido E. Rivera, H. Joachim Deeg, Juergen Thiele, Hans M. Kvasnicka, James W. Vardiman, Yanming Zhang, B. Nebiyou Bekele, Ruben A. Mesa, Robert P. Gale, Hagop M. Kantarjian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

174 Scopus citations

Fingerprint Dive into the research topics of 'Pomalidomide is active in the treatment of anemia associated with myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences